Thursday, September 24, 2020

Cipla gets final nod from USFDA for multiple sclerosis drug

Cipla gets final nod from USFDA for multiple sclerosis drug The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc#39;#39;s Tecfidera.

from Moneycontrol Business News https://ift.tt/32ZecRt

No comments:

Post a Comment

Market moves driven more by psychology than fundamentals: Samir Arora

Indian stock markets are caught between global worries and strong domestic company profits. Foreign investor activity, oil price swings, and...